Y, L., Y, L., Z, Y., R, W., & Y, J. (2024). Sequential autologous CAR-T and allogeneic CAR-T therapy successfully treats central nervous system involvement relapsed/refractory ALL: A case report and literature review. Frontiers in oncology, 14, 1341682. https://doi.org/10.3389/fonc.2024.1341682
Chicago Style (17th ed.) CitationY, Liu, Li Y, Yu Z, Wang R, and Jing Y. "Sequential Autologous CAR-T and Allogeneic CAR-T Therapy Successfully Treats Central Nervous System Involvement Relapsed/refractory ALL: A Case Report and Literature Review." Frontiers in Oncology 14 (2024): 1341682. https://doi.org/10.3389/fonc.2024.1341682.
MLA (9th ed.) CitationY, Liu, et al. "Sequential Autologous CAR-T and Allogeneic CAR-T Therapy Successfully Treats Central Nervous System Involvement Relapsed/refractory ALL: A Case Report and Literature Review." Frontiers in Oncology, vol. 14, 2024, p. 1341682, https://doi.org/10.3389/fonc.2024.1341682.